Multiple studies have indicated a positive correlation between the level of CK-18 and the occurrence of MASH, at the same time confirming its high sensitivity and specificity in the diagnosis of this stage of MASLD [34,35,36]. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.